Alcohol consumption and not metabolic abnormalities is associated with increased hepatocellular carcinoma risk in patients with End-Stage Liver Disease

被引：0
|
作者：
Tamimi, Tarek I. Abu-Rajab
Hanouneh, Ibrahim A.
Hazin, Ribhi
Lopez, Rocio
Zein, Nizar N.
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A824 / A824
页数：1
相关论文
共 50 条
  • [31] Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons
    Ryom, Lene
    Lundgren, Jens Dilling
    De Wit, Stephane
    Kovari, Helen
    Reiss, Peter
    Law, Matthew
    El-Sadr, Wafa
    Monforte, Antonella D'Arminio
    Mocroft, Amanda
    Smith, Colette
    Fontas, Eric
    Dabis, Francois
    Phillips, Andrew
    Sabin, Caroline
    [J]. AIDS, 2016, 30 (11) : 1731 - 1743
  • [32] Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systems
    Lee, Yun-Hsuan
    Hsu, Chia-Yang
    Hsia, Cheng-Yuan
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Lin, Han-Chieh
    Loong, Che-Chuan
    Chiou, Yi-You
    Huo, Teh-Ia
    [J]. DIGESTIVE AND LIVER DISEASE, 2012, 44 (10) : 868 - 874
  • [33] Radio-Pathologic Correlation and Assessment of Patients with End-Stage Liver Disease and Hepatocellular Carcinoma Undergoing Liver Transplantation
    Fiel, M. I.
    Ward, S.
    Thung, S.
    Trivedi, A.
    Fenster, A.
    Florman, S.
    Schiano, T. D.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 420A - 420A
  • [34] Radio-Pathologic Correlation and Assessment of Patients with End-Stage Liver Disease and Hepatocellular Carcinoma Undergoing Liver Transplantation
    Fiel, M. I.
    Ward, S.
    Thung, S.
    Trivedi, A.
    Fenster, A.
    Florman, S.
    Schiano, T. D.
    [J]. MODERN PATHOLOGY, 2014, 27 : 420A - 420A
  • [35] High frequency of chronic end-stage liver disease and hepatocellular carcinoma in a Hispanic population
    Perez, A
    Anzaldua, M
    McCormick, J
    Fisher-Hoch, S
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (03) : 289 - 295
  • [36] PNPLA3 IN END-STAGE LIVER DISEASE: ALCOHOL CONSUMPTION, HCC DEVELOPMENT AND LIVER TRANSPLANTATION
    Friedrich, K.
    Rupp, C.
    Wannhoff, A.
    Schemmer, P.
    Stremmel, W.
    Gotthardt, D.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 51 - 51
  • [37] PNPLA3 in end-stage liver disease: alcohol consumption, HCC development and liver transplantation
    Friedrich, Kilian
    Wannhoff, Andreas
    Rupp, Christian
    Weiss, Karl Heinz
    Schemmer, Peter
    Stremmel, Wolfgang
    Gotthardt, Daniel
    [J]. HEPATOLOGY, 2013, 58 : 1234A - 1234A
  • [38] Prevalence and Risk Factors of Cardiac Abnormalities in Patients with End-Stage Renal Disease
    Rivera, D. M. Torpoco
    Jain, A.
    Kapur, G.
    Nakdali, M.
    Aggarwal, S.
    Sehgal, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S610 - S611
  • [39] Prevalence of myocardial perfusion abnormalities in end-stage liver disease
    Fathala, Ahmed
    Safar, Bander
    Al Muhaideb, Ahmed
    [J]. INDIAN JOURNAL OF NUCLEAR MEDICINE, 2011, 26 (01): : 7 - 10
  • [40] Metabolic dysfunction associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Kim, Aryoung
    Choi, Sung Chul
    Goh, Myungji
    Kang, Wonseok
    Gwak, Geum-Yon
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    Sinn, Dong Hyun
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S631 - S631
12345